Middle East and Africa High Throughput Screening Market Size, Share, Trends & Growth Forecast Report By Product, By Technology, By Application, By End User and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of Middle East and Africa) – Industry Analysis, 2025 to 2033

ID: 6293
Pages: 145

Middle East and Africa High Throughput Screening Market Size

The size of the Middle East and Africa high throughput screening market was worth USD 30.77 billion in 2024. The market is anticipated to grow at a CAGR of 6.9% from 2025 to 2033 and be worth USD 56.10 billion by 2033 from USD 32.89 billion in 2025.

The Middle East and Africa high throughput screening market is projected to hit $56.10 bn by 2033.

MARKET DRIVERS

Technological Advancements and Rising Demand for Drug Discovery Tools

The rise in the number of potential drug targets and advancements in technologies leading to the emergence of innovative technologies and platforms like analytical tools that deal with massive amounts of data drive market growth. In addition, growth in demand for high throughput screening devices in stem cell research for assessing excretion, metabolism, distribution, and absorption characteristics and investigation of functional activity are significant drivers of the Middle East and Africa high throughput screening market. Also, the availability of government funding, collaborations of research, and academic institutions with pharmaceutical industries for developing innovative ways for drug delivery are further catalyzing the growth of the Middle East and Africa high throughput screening market.

The factors that provide growth opportunities for expanding the high throughput screening market during the forecast period are the evolution of preclinical drug development and discovery systems by adopting human stem cell-based high throughput screenings and assays. Emerging economies of countries are increasing the market's growth opportunities due to rapid growth in pharmaceutical industries and the integration of innovative technologies, a significant push for research by governments of these countries in the life sciences industry.

MARKET RESTRAINTS

High Costs and Budget Constraints in Research and Automation

Restraints challenging the growth of the high throughput screening market are costs, the requirement of extensive automation techniques, the capital-intensive nature, and budget restrictions for academic research purposes. There is an increased requirement for instruments in biotechnological and pharmacy companies, resulting in a notable rise in these companies' capital costs that are expected to limit the Middle East and Africa high throughput screening market during the forecast period.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2024 to 2033

Base Year

2024

Forecast Period

2025 to 2033

Segments Covered

By Product, Technology, Application, End User, and Region.

Various Analyses Covered

Global, Regional and Country-Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges; PESTLE Analysis; Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview of Investment Opportunities

Countries Covered

KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of Middle East and Africa

Market Leaders Profiled

Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A.

REGIONAL ANALYSIS

Regionally, South Africa and Saudi Arabia witnessed to grow with the highest CAGR in the Middle East and Africa high throughput screening market during the forecast period. Technological advancements in high throughput growing pharmaceutical research and development expenses are likely to fuel the market growth during the historical period. In addition, the availability of funds from the government integrated with developing common diseases is propelling the market.

Other countries like UAE, Ethiopia, Israel, Sudan, Kenya, Egypt, and the rest of the Middle East and Africa are expected to grow in the region's market.

KEY MARKET PARTICIPANTS

Agilent Technologies Inc., Danaher Corporation, Thermo Fisher Scientific Inc., PerkinElmer Inc., Tecan Group Ltd., Millipore, Bio-Rad Laboratories, Hamilton Company, Axxam S.p.A., and Aurora Biomed are some of the notable companies in the Middle East and Africa high throughput screening market.

MARKET SEGMENTATION

This research report on the Middle East and Africa high throughput screening market has been segmented and sub-segmented into the following categories

By Product

  • Consumables And Reagents

  • Instruments
  • Software And Services

By Technology

  • Cell-based Assays

  • Lab-on-a-chip
  • Ultra-High-Throughput Screening
  • Label-Free Technology
  • Bioinformatics

By Application

  • Target Identification

  • Primary Screening
  • Toxicology
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies

  • Academic and Government Research Institutes
  • Contract Research Organizations
  • Other End Users

By Country

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of Middle East and Africa

Trusted by 500+ companies. We respect your privacy and never share your data.

Please wait. . . . Your request is being processed

Frequently Asked Questions

What is the growth rate of the MEA high throughput screening market?

The MEA high throughput screening market is expected to grow at a CAGR of 6.9% from 2022 to 2027.

Who are the key players in the MEA high throughput screening market?

Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer, and Merck KGaA are some of the notable companies in the MEA high throughput screening market.

What are the key factors driving the growth of the MEA high throughput screening market?

Factors such as the growing prevalence of chronic diseases, growing demand for personalized medicine, and advancements in technology that enable more efficient and cost-effective screening are propelling the MEA high throughput screening market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1600

Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM

Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!

REACH OUT TO US

Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: sales@marketdataforecast.com

Click for Request Sample